Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 April 2020 | Story Nitha Ramnath | Photo Sonia Small
Students on Campus
UFS accounting students are flying the Kovsie flag high.

The School of Accountancy is proud to announce that 55 (74%) of the 2019 graduates for the BAcc Honours and Postgraduate Diploma in Chartered Accountancy programmes have passed the Initial Test of Competence (ITC) examination for the Chartered Accountant (SA) designation, compared to the national average of 68% for first-time candidates.

The results were recently released by the South African Institute of Chartered Accountants (SAICA). The ITC examination is the first of two professional examinations required for qualification as a chartered accountant (SA), and is written shortly after completing formal university studies, with two sittings of this examination annually, i.e. in January and June.

Of the 2019 Thuthuka Bursary Programme, seven out of eight graduates passed, translating into an 88% pass rate for this group.

Prof Frans Prinsloo, Director of the School of Accountancy, said: “I am pleased to report that these results confirm the quality and excellence of our CA programmes – a point repeatedly noted by the SAICA monitoring team during their formal feedback session last week.  These results are also testament to the hard work and dedication of the academic staff in the school.”

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept